Long-Term Liabilities: The sum of all non-current liabilities.
Sanofi (SNY) had Long-Term Liabilities of $26.60B for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
$11.17B |
|
$1.97B |
|
$3.04B |
|
$8.13B |
|
$8.73B |
|
$2.44B |
|
$-169.61M |
|
$2.27B |
|
$2.30B |
|
$1.77B |
|
$1.81B |
|
$1.99B |
|
$1.80B |
|
$2.44B |
|
$2.44B |
|
2.47B |
|
2.47B |
|
$0.80 |
|
$0.80 |
|
Balance Sheet Financials | |
$46.37B |
|
$10.34B |
|
$92.57B |
|
$138.95B |
|
$33.94B |
|
$12.40B |
|
Long-Term Liabilities |
$26.60B |
$60.55B |
|
-- |
|
$11.18B |
|
$78.40B |
|
-- |
|
Cash Flow Statement Financials | |
$2.20B |
|
$-817.52M |
|
$-623.67M |
|
$7.84B |
|
$8.42B |
|
$579.42M |
|
-- |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.37 |
|
-- |
|
-- |
|
0.14 |
|
0.26 |
|
72.76% |
|
21.86% |
|
21.86% |
|
-- |
|
20.35% |
|
17.65% |
|
$2.20B |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.13 |
|
23.73 |
|
3.79 |
|
-- |
|
16.20% |
|
1.30% |
|
1.99% |
|
-- |
|
$0.89 |
|
$0.89 |